CRAVERO, PAOLA
 Distribuzione geografica
Continente #
AS - Asia 1.657
NA - Nord America 524
EU - Europa 334
SA - Sud America 142
AF - Africa 34
OC - Oceania 2
Totale 2.693
Nazione #
CN - Cina 544
US - Stati Uniti d'America 505
SG - Singapore 481
VN - Vietnam 274
KR - Corea 122
BR - Brasile 102
HK - Hong Kong 99
IT - Italia 98
FR - Francia 55
DE - Germania 46
IN - India 40
NL - Olanda 37
FI - Finlandia 32
JP - Giappone 26
AR - Argentina 20
GB - Regno Unito 19
CI - Costa d'Avorio 11
ID - Indonesia 11
PH - Filippine 11
TH - Thailandia 11
CA - Canada 10
RU - Federazione Russa 9
MX - Messico 8
SC - Seychelles 8
ZA - Sudafrica 8
BD - Bangladesh 7
IE - Irlanda 7
SE - Svezia 7
TR - Turchia 7
CO - Colombia 5
EC - Ecuador 5
PL - Polonia 5
IQ - Iraq 4
AT - Austria 3
PE - Perù 3
PY - Paraguay 3
TW - Taiwan 3
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LS - Lesotho 1
MA - Marocco 1
ME - Montenegro 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
TN - Tunisia 1
UA - Ucraina 1
YE - Yemen 1
Totale 2.693
Città #
Singapore 365
Hefei 301
Seoul 119
Ashburn 110
San Jose 106
Hong Kong 93
Ho Chi Minh City 81
Hanoi 57
Council Bluffs 33
Beijing 32
Lauterbourg 28
Bengaluru 26
Santa Clara 25
Munich 22
Tokyo 21
Los Angeles 18
Bologna 15
Frankfurt am Main 13
Haiphong 13
Helsinki 13
Chicago 12
Abidjan 11
Turku 11
Fairfield 10
Redondo Beach 10
Tongling 10
Da Nang 9
Milan 9
Boardman 8
Dallas 8
Lappeenranta 8
New York 8
Dublin 7
Houston 7
Buffalo 6
Chandler 6
Rancho Palos Verdes 6
Seattle 6
São Paulo 6
Abbadia San Salvatore 5
Biên Hòa 5
Elk Grove Village 5
Jakarta 5
Johannesburg 5
Mexico City 5
Rome 5
Amsterdam 4
Cambridge 4
Hillsboro 4
Hải Dương 4
London 4
Montreal 4
Salt Lake City 4
San Lazzaro di Savena 4
Atlanta 3
Barranquilla 3
Bắc Ninh 3
Denver 3
Düsseldorf 3
Istanbul 3
Pattaya 3
Rio de Janeiro 3
Rosario 3
San Francisco 3
Southend 3
Tampa 3
Thái Nguyên 3
Treviso 3
Wilmington 3
Woodbridge 3
Wroclaw 3
Araxá 2
Asunción 2
Baghdad 2
Bang Phli 2
Bari 2
Bekasi 2
Berlin 2
Bern 2
Bogotá 2
Brasília 2
Campos dos Goytacazes 2
Can Tho 2
Cape Town 2
Charlotte 2
Chengdu 2
Curitiba 2
Dalian 2
Embu das Artes 2
Guangzhou 2
Guayaquil 2
Hyderabad 2
Imola 2
Lanús 2
Madrid 2
Montevideo 2
Nha Trang 2
Nuremberg 2
Palermo 2
Phuket 2
Totale 1.825
Nome #
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 211
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: A prospective observational protocol 189
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 149
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival 147
Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation 147
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 145
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis 136
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients 133
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer 133
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience 133
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 129
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer 128
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy 125
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer 121
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 109
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients 98
Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes 91
New generation anaplastic lymphoma kinase inhibitors 77
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy 65
Role of liquid biopsy in oncogene-addicted non-small cell lung cancer 59
Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy 50
Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection 47
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer 44
The use of methadone in Italian hospices: an updated survey 40
Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With MET Exon 14-Mutant NSCLC 37
Targeting RET-rearranged non-small-cell lung cancer: future prospects 16
Totale 2.759
Categoria #
all - tutte 5.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202223 1 4 1 1 2 1 1 0 1 0 9 2
2022/202328 1 1 0 4 2 3 0 2 6 2 3 4
2023/202427 1 1 2 1 2 1 0 4 5 3 3 4
2024/2025643 10 25 12 18 22 9 11 12 1 146 124 253
2025/20262.007 294 324 214 237 185 59 134 132 331 97 0 0
Totale 2.759